Browsing Tag
Casppian Phase 3 trial
1 post
Foresee Pharmaceuticals gains third DSMB endorsement for Casppian Phase 3 study, strengthening confidence in long-acting Leuprolide formulation
The latest safety review supports Foresee Pharmaceuticals’ continued progress in developing a long-acting leuprolide injectable emulsion for pediatric…